Trace Genomics raises oversubscribed $ 10.5 million Series B

Trace Genomics (Trace), the industry leader in DNA-based soil intelligence, announced its Series B funding round at $ 10.5 million led by existing investors S2G Ventures and Ajax Strategies, as well as new investor Rabo Ventures.

With this additional funding, Trace plans to expand its commercial growth, making its offerings available to more farmers and agronomists. Trace Genomics has developed a way to understand what’s happening beneath the surface of our farms. By examining the DNA of organisms in soil, farmers can get an individualized and detailed picture of soil health. This approach not only highlights what’s going on with the soil right now but also helps farmers make better decisions for their crops in the future.

Identify potential diseases

Trace Genomics helps farmers identify potential diseases before they become a problem, understand the soil’s fertility levels, and offer personalized recommendations to improve crop health and yield. This means farmers can grow more with less, using the optimal biologicals and chemicals, and making farming more sustainable for all.

In 2024-’25, Trace is set to broaden its reach, aiming to deliver its data and insights to an increased number of growers and agronomists, building on both existing and new partnerships. To support this growth, the company announced the addition of two key leaders to its team.

This strategic expansion builds upon the launch of its product TraceCOMPLETE, the establishment of key commercial partnerships in the US and Canada, the refinement of its commercial strategy for enhanced market penetration, and compelling stories from farmers and agronomists about how Trace’s insights have improved their financial outcomes.